K13* (p.Lys13Ter) variant of NAT2 (Arylamine N-acetyltransferase 2)
K13* (p.Lys13Ter) in NAT2 (Arylamine N-acetyltransferase 2) is a protein-truncating change. Clinical records from UniProt describe it as variant assessed as somatic; high impact. The record also includes structural context.
K13* (p.Lys13Ter) variant details
- p.Lys13Ter
- NCI-TCGA TCGA novel
- Variant assessed as somatic; high impact.
- Stop Gained
- UniProt: Variant assessed as somatic; high impact.
- Structural context available